Next Article in Journal
Knowledge, Attitude, and Practices of Antibiotics and Antibiotic Resistance Among Chinese Pharmacy Customers: A Multicenter Survey Study
Previous Article in Journal
Evaluation of Oxytetracycline Metabolites Cross-Reactivity with Oxytetracycline Enzyme-Linked Immunosorbent Assay (ELISA)
Article

Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant Escherichia coli Isolates from Livestock

1
Department of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea
2
Bacterial Disease Division, Animal and Plant Quarantine Agency, Gimcheon-si, Gyeongsangbuk-do 39660, Korea
*
Author to whom correspondence should be addressed.
Received: 18 March 2020 / Revised: 13 April 2020 / Accepted: 13 April 2020 / Published: 16 April 2020
(This article belongs to the Section The Global Need for Effective Antibiotics)
The increasing prevalence of antimicrobial resistance and the laborious development of novel antimicrobial agents have limited the options for effective antimicrobial therapy. The combination of previously used antimicrobial agents represents an alternative therapy for multidrug-resistant (MDR) pathogens. The objective of this study was to investigate the synergistic effect of a florfenicol (FFL)-based combination with other antimicrobial agents against MDR Escherichia coli isolates from livestock using checkerboard assays and murine infection models. The FFL/amikacin (AMK) and FFL/gentamicin (GEN) combinations showed synergy against 10/11 and 6/11 MDR E. coli isolates in vitro, respectively. The combination of FFL with aminoglycosides (AMK or GEN) exhibited a better synergistic effect against MDR E. coli isolates than the cephalothin (CEF)/GEN or FFL/CEF combinations. The combination of FFL with AMK or GEN could reduce the emergence of resistant mutants in vitro. The FFL/AMK combination showed a higher survival rate of mice infected with MDR E. coli isolates than FFL or AMK alone. In summary, the combination of FFL with aminoglycosides (AMK or GEN) is highly effective against MDR E. coli isolates both in vitro and in vivo. Our findings may contribute to the discovery of an effective combination regimen against MDR E. coli infections in veterinary medicine. View Full-Text
Keywords: antimicrobial agent; combination therapy; synergy; florfenicol; aminoglycosides antimicrobial agent; combination therapy; synergy; florfenicol; aminoglycosides
Show Figures

Figure 1

MDPI and ACS Style

Kim, S.; Woo, J.H.; Jun, S.H.; Moon, D.C.; Lim, S.-K.; Lee, J.C. Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant Escherichia coli Isolates from Livestock. Antibiotics 2020, 9, 185. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9040185

AMA Style

Kim S, Woo JH, Jun SH, Moon DC, Lim S-K, Lee JC. Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant Escherichia coli Isolates from Livestock. Antibiotics. 2020; 9(4):185. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9040185

Chicago/Turabian Style

Kim, Shukho; Woo, Jung H.; Jun, So H.; Moon, Dong C.; Lim, Suk-Kyung; Lee, Je C. 2020. "Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant Escherichia coli Isolates from Livestock" Antibiotics 9, no. 4: 185. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9040185

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop